z-logo
Premium
Targeted Drug Delivery and Penetration Into Solid Tumors
Author(s) -
Corti Angelo,
Pastorino Fabio,
Curnis Flavio,
Arap Wadih,
Ponzoni Mirco,
Pasqualini Renata
Publication year - 2012
Publication title -
medicinal research reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.868
H-Index - 130
eISSN - 1098-1128
pISSN - 0198-6325
DOI - 10.1002/med.20238
Subject(s) - penetration (warfare) , drug , solid tumor , drug delivery , medicine , targeted drug delivery , pharmacology , nanotechnology , cancer , materials science , engineering , operations research
Delivery and penetration of chemotherapeutic drugs into tumors are limited by a number of factors related to abnormal vasculature and altered stroma composition in neoplastic tissues. Coupling of chemotherapeutic drugs with tumor vasculature‐homing peptides or administration of drugs in combination with biological agents that affect the integrity of the endothelial lining of tumor vasculature is an appealing strategy to improve drug delivery to tumor cells. Promising approaches to achieve this goal are based on the use of Asn‐Gly‐Arg (NGR)‐containing peptides as ligands for drug delivery and of NGR‐TNF, a peptide‐tumor necrosis factor‐α fusion protein that selectively alters drug penetration barriers and that is currently tested in a randomized Phase III trial in patients with malignant pleural mesothelioma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here